NLRP3 and cholesteatoma: In one study, expression of NLRP3 in middle-ear samples was compared between cochlear implant surgery patients with COM with cholesteatoma and those with COM and normal middle-ear mucosa through reverse transcription polymerase chain reaction (RT-PCR) analysis and immunohistochemical studies.